Lynwood Capital Management »

Altimmune shares owned by Lynwood Capital Management

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Lynwood Capital Management from 13F filings

Historical chart of Lynwood Capital Management investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by Lynwood Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by Lynwood Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.5M 150k 10.18

More positions owned by Lynwood Capital Management

Briacell Therapeutics Corp (BCTX)
Americas Gold And Silver Cor (USAS)
Vaneck Etf Trust Gold Miners Etf (GDX)
Altimmune Com New (ALT)
Immix Biopharma (IMMX)
Advanced Micro Devices (AMD)
Teck Resources CL B (TECK)
Petroleo Brasileiro Sa Petro Sponsored Adr (PBR)
Spire Global Com Cl A New (SPIR)
Sociedad Quimica Y Minera De Spon Adr Ser B (SQM)
Vermilion Energy (VET)
Lightspeed Commerce Sub Vtg Shs (LSPD)
Diamond Offshore Drilli (DO)
Mag Silver Corp (MAG)
Transocean Registered Shs (RIG)

View all positions for Lynwood Capital Management

Top funds holding Altimmune

BlackRock
Vanguard Group
Tang Capital Management
Morgan Stanley
Susquehanna International
Ameriprise Financial
Millennium Management
Geode Capital Management
Fred Alger Management
Nuveen Asset Management
Portolan Capital Management
Rafferty Asset Management
Goldman Sachs Group
Readystate Asset Management
Citigroup

View all funds holding Altimmune